Hims & Hers Health, Inc.
NYSEHims & Hers Health enters the week with the stock down another 4% — extending a bruising month that has now erased nearly 14% — while short interest edges quietly higher and the analyst community tries to find a floor. The most important thing the positioning data says right now is that shorts are not capitulating. Short interest has ticked back up to 26.5% of the free float…
HIMS short interest utilization hits 92.06%, matching 52-week peak as earnings loom.
Hims & Hers Health enters the week with the stock down another 4% — extending a bruising month that has now erased nearly 14% — while short interest edges quietly higher and the analyst community tries to find a…
Hims & Hers Health has handed back a chunk of the 16% rally flagged in the prior note, falling 10.4% on the week to close at $28.44 — a sharp reversal that reopens the question of whether that move was genuine demand…
Snapshot as of 21 Sept 2026
Hims & Hers Health has staged a sharp reversal this week — up 16% to $31.75 — flipping the script on a note filed just days ago that described extreme hedging demand and relentless selling pressure. The positioning…
Hims & Hers Health is caught in a widening gap between a Street that nudged targets higher after earnings and a market that keeps selling the stock — down another 10% on the week to $27.39, extending a month-long…
Hims & Hers Health reported Q2 results on August 10 and the reaction was swift and negative — the stock fell 3.4% the next day and is now down 5.1% on the week to $30.51, extending a month-long slide of more than…
Hims & Hers Health heads into its August 3 earnings report with short interest re-entrenched, options positioning nudging more cautious, and a stock that just bounced 8% on Thursday after losing 17% over the prior…
Hims & Hers Health arrives at its August 3 earnings report with a week of contradictory signals: short interest nudged back up, the stock shed 10% in five sessions, yet the borrow market is quietly loosening and…
Hims & Hers Health enters its August 3 earnings report in a genuinely unusual place: short sellers have been cutting positions for weeks, yet options traders just turned more defensive than they've been in months. The…
Hims & Hers Health heads into the week before its August 3 earnings with the short position still enormous but the acute squeeze pressure of late June clearly unwinding. The lending market has shifted meaningfully…
Hims & Hers Health enters July with an unusual tension at its core: the stock has rallied 33% in a month while short sellers continue adding to what is already one of the largest short positions in healthcare…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HIMS — free to start on ORTEX.
Sign up for free →Open HIMS on ORTEX